BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36309484)

  • 1. EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling.
    Wang Y; Chen P; Zhao M; Cao H; Zhao Y; Ji M; Hou P; Chen M
    Cell Death Dis; 2022 Oct; 13(10):910. PubMed ID: 36309484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.
    Regales L; Gong Y; Shen R; de Stanchina E; Vivanco I; Goel A; Koutcher JA; Spassova M; Ouerfelli O; Mellinghoff IK; Zakowski MF; Politi KA; Pao W
    J Clin Invest; 2009 Oct; 119(10):3000-10. PubMed ID: 19759520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.
    Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L
    Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
    Chang H; Sung JH; Moon SU; Kim HS; Kim JW; Lee JS
    Yonsei Med J; 2017 Jan; 58(1):9-18. PubMed ID: 27873490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma.
    Wang FY; Wang-Gou SY; Cao H; Jiang N; Yang Q; Huang Q; Huang CH; Li XJ
    Cancer Commun (Lond); 2020 Oct; 40(10):518-530. PubMed ID: 32888253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia Induces Multidrug Resistance via Enhancement of Epidermal Growth Factor-Like Domain 7 Expression in Non-Small Lung Cancer Cells.
    Shen X; Zhi Q; Wang Y; Li Z; Zhou J; Huang J
    Chemotherapy; 2017; 62(3):172-180. PubMed ID: 28351036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
    Hsu PC; Jablons DM; Yang CT; You L
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.
    Nguyen KS; Kobayashi S; Costa DB
    Clin Lung Cancer; 2009 Jul; 10(4):281-9. PubMed ID: 19632948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.
    Park KS; Raffeld M; Moon YW; Xi L; Bianco C; Pham T; Lee LC; Mitsudomi T; Yatabe Y; Okamoto I; Subramaniam D; Mok T; Rosell R; Luo J; Salomon DS; Wang Y; Giaccone G
    J Clin Invest; 2014 Jul; 124(7):3003-15. PubMed ID: 24911146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions.
    Kato Y; Ninomiya K; Ohashi K; Tomida S; Makimoto G; Watanabe H; Kudo K; Matsumoto S; Umemura S; Goto K; Ichihara E; Ninomiya T; Kubo T; Sato A; Hotta K; Tabata M; Toyooka S; Maeda Y; Kiura K
    Cancer Sci; 2018 Oct; 109(10):3149-3158. PubMed ID: 30053332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFL7 affects the migration of epidermal stem cells in refractory diabetic wounds by regulating Notch signaling pathway.
    Chang J; Sun Y; Meng X; Zeng F; Wang X
    Regen Med; 2023 Feb; 18(2):137-153. PubMed ID: 36530156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET inhibition downregulates DR4 expression in MET-amplified lung cancer cells with acquired resistance to EGFR inhibitors through suppressing AP-1-mediated transcription.
    Deng L; Vallega KA; Zhang S; Shi P; Sun SY
    Neoplasia; 2021 Aug; 23(8):766-774. PubMed ID: 34233230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal.
    Schmidt MHH; Bicker F; Nikolic I; Meister J; Babuke T; Picuric S; Müller-Esterl W; Plate KH; Dikic I
    Nat Cell Biol; 2009 Jul; 11(7):873-80. PubMed ID: 19503073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.
    Shah KN; Bhatt R; Rotow J; Rohrberg J; Olivas V; Wang VE; Hemmati G; Martins MM; Maynard A; Kuhn J; Galeas J; Donnella HJ; Kaushik S; Ku A; Dumont S; Krings G; Haringsma HJ; Robillard L; Simmons AD; Harding TC; McCormick F; Goga A; Blakely CM; Bivona TG; Bandyopadhyay S
    Nat Med; 2019 Jan; 25(1):111-118. PubMed ID: 30478424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
    Zhang Z; Lee JC; Lin L; Olivas V; Au V; LaFramboise T; Abdel-Rahman M; Wang X; Levine AD; Rho JK; Choi YJ; Choi CM; Kim SW; Jang SJ; Park YS; Kim WS; Lee DH; Lee JS; Miller VA; Arcila M; Ladanyi M; Moonsamy P; Sawyers C; Boggon TJ; Ma PC; Costa C; Taron M; Rosell R; Halmos B; Bivona TG
    Nat Genet; 2012 Jul; 44(8):852-60. PubMed ID: 22751098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFL7 silencing inactivates the Notch signaling pathway; enhancing cell apoptosis and suppressing cell proliferation in human cutaneous melanoma.
    Tang H; Xiao WR; Liao YY; Li L; Xiao X; Xu XP; Feng H
    Neoplasma; 2019 Mar; 66(2):187-196. PubMed ID: 30569717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.
    de Oliveira C; Martins SFF; Gonçalves PG; Limone GA; Longatto-Filho A; Reis RM; Bidinotto LT
    Sci Rep; 2023 Nov; 13(1):19783. PubMed ID: 37957249
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hu C; Zhou A; Hu X; Xiang Y; Huang M; Huang J; Yang D; Tang Y
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.